Press Release
AMOEBA announces update of the regulatory calendar in the United States of America
Lyon, 27th December 2016 - AMOEBA (FR0011051598 - AMEBA), the producer of a biological biocide capable of eliminating the risk of waterborne bacteria, announces today that BIOMEBA registration needed for the marketing on US territory is deferred.
The registration dossier submitted to the Environmental Protection Agency (EPA) has needed a complementary study to be performed by AMOEBA, resulting in the Company becoming required to re-file the dossier. This study has been positively completed and will match EPA request. As the instruction time is estimated at 18 months, the Company considers that the BIOMEBA may be registered in the second half of 2018.
This new application however allows the Company to expand the possible applications of BIOMEBA in the USA, in non-food crop irrigation and aquaculture, which market is estimated at 200 million euros that will complement the 510 million euros of global cooling tower market.
Lastly, the company is exploring the feasibility to charge services in the USA within a R&D framework in cooling tower application from the second quarter of 2017, which was not initially planned.
"This new application does not impact the company as we did not plan industrial production capacities in North America before 2018 through the production units in Canada", stated Fabrice PLASSON, President of AMOEBA's Board of Directors.
About AMOEBA: AMOEBA develops a biological biocide capable of eliminating waterborne bacterial risk (legionella, pseudomonas, listeria, etc.). This entirely natural solution is presented as an alternative to the chemical treatments traditionally used in the industrial sector and complies with the new regulations in terms of chemical emissions into the environment. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today concentrating on the segment of industrial air-cooled towers (ACT), estimated to be worth EUR 1.7bn (2). AMOEBA is pursuing the regulatory procedures to obtain the provisional MA for all European countries in "Cooling Towers" application. Based in Chassieu - France. AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index. For more information: www.amoeba-biocide.com.
(1) : Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets
(2) : Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Contacts :
| Amoeba Nathalie COMBROUSSE Marketing Communication Manager +33 (0)4 81 09 18 15 nathalie.combrousse@amoeba-biocide.com | Actifin Ghislaine GASPARETTO Financial Communication +33(0)1 56 88 11 11 ggasparetto@actifin.fr |
http://www.globenewswire.com/NewsRoom/AttachmentNg/728f0fab-8ae2-4c1a-a3d0-909e1b22026d
